Description

The global in vitro diagnostics market is poised to grow by US$ 37.8 billion during 2022-2028, progressing at a CAGR of 6.1% during the forecast period, according to data and analytics company StrategyHelix.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for in vitro diagnostics. The global in vitro diagnostics market is segmented on the basis of product, technology, application, end user, and region. By product, the global in vitro diagnostics market has been segmented into instruments, reagents, software & services. Based upon technology, the global in vitro diagnostics market is categorized into clinical chemistry & immunochemistry, clinical microbiology, hematology, molecular diagnostics (MDx), POC testing, self-monitoring of blood glucose (SMBG), tissue diagnostics, others. In 2021, the clinical chemistry & immunochemistry segment made up the largest share of revenue generated by the in vitro diagnostics market. On the basis of application, the global in vitro diagnostics market has been segmented into autoimmune diseases, cardiac diseases, diabetes, infectious diseases, nephrological diseases, oncology, others. By end user, the global in vitro diagnostics market has been segmented into hospitals, laboratories, homecare, others. Geographically, the global in vitro diagnostics market is segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global in vitro diagnostics market is highly competitive. Key companies profiled in the report include Abbott Laboratories, Becton Dickinson and Company, bioMerieux S.A., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Illumina Inc., Ortho-Clinical Diagnostics Inc., PerkinElmer Inc., Qiagen N.V., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Werfen S.A. Competitive landscape gives a description of the competitive nature of the global in vitro diagnostics market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the in vitro diagnostics market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product: instruments, reagents, software & services
Technology: clinical chemistry & immunochemistry, clinical microbiology, hematology, molecular diagnostics (MDx), POC testing, self-monitoring of blood glucose (SMBG), tissue diagnostics, others
Application: autoimmune diseases, cardiac diseases, diabetes, infectious diseases, nephrological diseases, oncology, others
End user: hospitals, laboratories, homecare, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: Abbott Laboratories, Becton Dickinson and Company, bioMerieux S.A., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Illumina Inc., Ortho-Clinical Diagnostics Inc., PerkinElmer Inc., Qiagen N.V., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., Werfen S.A.

Key Benefits for Stakeholders

– Get a comprehensive picture of the global in vitro diagnostics market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. In vitro diagnostics market overview
Part 3. Market breakdown by product
– Instruments
– Reagents
– Software & services
Part 4. Market breakdown by technology
– Clinical chemistry & immunochemistry
– Clinical microbiology
– Hematology
– Molecular diagnostics (MDx)
– POC testing
– Self-monitoring of blood glucose (SMBG)
– Tissue diagnostics
– Others
Part 5. Market breakdown by application
– Autoimmune diseases
– Cardiac diseases
– Diabetes
– Infectious diseases
– Nephrological diseases
– Oncology
– Others
Part 6. Market breakdown by end user
– Hospitals
– Laboratories
– Homecare
– Others
Part 7. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 8. Key companies
– Abbott Laboratories
– Becton, Dickinson and Company
– bioMerieux S.A.
– Bio-Rad Laboratories, Inc.
– Danaher Corporation
– F. Hoffmann-La Roche AG
– Hologic, Inc.
– Illumina, Inc.
– Ortho-Clinical Diagnostics, Inc.
– PerkinElmer, Inc.
– Qiagen N.V.
– Siemens Healthineers AG
– Sysmex Corporation
– Thermo Fisher Scientific, Inc.
– Werfen, S.A.
About StrategyHelix
Disclaimer